Kyverna Therapeutics, Inc.KYTXNASDAQ
LOADING
|||
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 12.37% |
| Q2 2025 | 5.83% |
| Q1 2025 | -18.39% |
| Q4 2024 | -8.75% |
| Q3 2024 | -19.40% |
| Q2 2024 | 40.18% |
| Q1 2024 | -133.33% |
| Q4 2023 | -33.33% |
| Q3 2023 | -20.00% |
| Q2 2023 | 30.23% |
| Q1 2023 | -115.00% |
| Q4 2022 | 0.00% |